Dasatinib monolauryl sulfate is a salt of dasatinib, a tyrosine kinase inhibitor medication used to treat certain types of blood cancer, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+). It is grouped under the following drug class(es): Antineoplastic agents and Kinase inhibitors. Its therapeutic use is listed as antineoplastics. The directory classifies it as a unknown/inactive API with a synthetic source/manufacturing origin. Other names for this substance include Dasatinib laurylsulfate. Its PubChem CID is 146048051.
Dasatinib monolauryl sulfate
| CAS No | 2398469-56-0 |
|---|---|
| Molecular Formula | C34H52ClN7O6S2 |
| Molecular Weight | 754.4 g/mol |
| Synonyms | N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;dodecyl hydrogen sulfate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Dasatinib monolauryl sulfate is a salt of dasatinib, a tyrosine kinase inhibitor medication used to treat certain types of blood cancer, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+).
The listed CAS number is 2398469-56-0.
The listed molecular formula is C34H52ClN7O6S2.
The listed molecular weight is 754.4 g/mol.
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;dodecyl hydrogen sulfate.
The source lists Dasatinib laurylsulfate.